Biogen Earnings Beat, But Full-Year Guidance Cut

Biogen Earnings Beat, But Full-Year Guidance Cut

Biogen earnings and sales fell less than expected in the third quarter, but the biotech giant cut its full-year revenue and earnings guidance, and BIIB stock fell in early trading Wednesday.